Evidence map›Paper›PMID 34299101›Full record

ArticleInternational journal of molecular sciences2021

COVID-19 in Children: Expressions of Type I/II/III Interferons, TRIM28, SETDB1, and Endogenous Retroviruses in Mild and Severe Cases.

Pier-Angelo Tovo, Silvia Garazzino, Valentina Daprà, Giulia Pruccoli, Cristina Calvi, Federica Mignone, Carla Alliaudi, Marco Denina, Carlo Scolfaro, Marisa Zoppo and 4 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. KAP1 in antiviral immunity: dual roles in viral silencing and immune regulation.Frontiers in cellular and infection microbiology · 2025
    Review
  6. Review
  7. Review
  8. IFN Lambda Deficiency Contributes to Severe COVID-19 Outcomes.International journal of molecular sciences · 2024
    Article
  9. Article
  10. Article
  11. Review
  12. Observational
  13. Human endogenous retroviruses and exogenous viral infections.Frontiers in cellular and infection microbiology · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Pier-Angelo TovoDepartment of Pediatric Sciences and Public Health, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.
Silvia GarazzinoInfectious Diseases Unit, Department of Pediatrics, Regina Margherita Children's Hospital, Piazza Polonia 94, 10126 Turin, Italy.ORCID 0000-0001-5773-5356
Valentina DapràPediatric Laboratory, Department of Pediatric Sciences and Public Health, University of Turin, 10126 Turin, Italy.
Giulia PruccoliDepartment of Pediatric Sciences and Public Health, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.
Cristina CalviDepartment of Pediatric Sciences and Public Health, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.
Federica MignoneInfectious Diseases Unit, Department of Pediatrics, Regina Margherita Children's Hospital, Piazza Polonia 94, 10126 Turin, Italy.ORCID 0000-0002-4954-1487
Carla AlliaudiDepartment of Pediatric Sciences and Public Health, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.
Marco DeninaDepartment of Pediatric Sciences and Public Health, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.ORCID 0000-0002-8495-1844
Carlo ScolfaroInfectious Diseases Unit, Department of Pediatrics, Regina Margherita Children's Hospital, Piazza Polonia 94, 10126 Turin, Italy.
Marisa ZoppoInfectious Diseases Unit, Department of Pediatrics, Regina Margherita Children's Hospital, Piazza Polonia 94, 10126 Turin, Italy.
Francesco LicciardiDepartment of Pediatric Sciences and Public Health, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.
Ugo RamenghiDepartment of Pediatric Sciences and Public Health, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.
Ilaria GallianoDepartment of Pediatric Sciences and Public Health, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.
Massimiliano BergalloDepartment of Pediatric Sciences and Public Health, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.
University of Turin · ITOspedale Regina Margherita · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Children with the new coronavirus disease 2019 (COVID-19) have milder symptoms and a better prognosis than adult patients. Several investigations assessed type I, II, and III interferon (IFN) signatures in SARS-CoV-2 infected adults, however no data are available for pediatric patients. TRIM28 and SETDB1 regulate the transcription of multiple genes involved in the immune response as well as of human endogenous retroviruses (HERVs). Exogenous viral infections can trigger the activation of HERVs, which in turn can induce inflammatory and immune reactions. Despite the potential cross-talks between SARS-CoV-2 infection and TRIM28, SETDB1, and HERVs, information on their expressions in COVID-19 patients is lacking. We assessed, through a PCR real time Taqman amplification assay, the transcription levels of six IFN-I stimulated genes, IFN-II and three of its sensitive genes, three IFN-lIIs, as well as of TRIM28, SETDB1, pol genes of HERV-H, -K, and -W families, and of env genes of Syncytin (SYN)1, SYN2, and multiple sclerosis-associated retrovirus (MRSV) in peripheral blood from COVID-19 children and in control uninfected subjects. Higher expression levels of IFN-I and IFN-II inducible genes were observed in 36 COVID-19 children with mild or moderate disease as compared to uninfected controls, whereas their concentrations decreased in 17 children with severe disease and in 11 with multisystem inflammatory syndrome (MIS-C). Similar findings were found for the expression of TRIM-28, SETDB1, and every HERV gene. Positive correlations emerged between the transcriptional levels of type I and II IFNs, TRIM28, SETDB1, and HERVs in COVID-19 patients. IFN-III expressions were comparable in each group of subjects. This preserved induction of IFN-λs could contribute to the better control of the infection in children as compared to adults, in whom IFN-III deficiency has been reported. The upregulation of IFN-I, IFN-II, TRIM28, SETDB1, and HERVs in children with mild symptoms, their declines in severe cases or with MIS-C, and the positive correlations of their transcription in SARS-CoV-2-infected children suggest that they may play important roles in conditioning the evolution of the infection.

Indexed as

Severity of Illness IndexCase-Control StudiesChildCOVID-19Endogenous RetrovirusesFemaleHistone-Lysine N-MethyltransferaseHumansInterferon-gammaInterferon LambdaInterferonsInterferon Type IItalyMaleSARS-CoV-2Tripartite Motif-Containing Protein 28Histone-Lysine N-MethyltransferaseInterferon-gammaInterferon LambdaInterferonsInterferon Type ISETDB1 protein, humanTRIM28 protein, humanTripartite Motif-Containing Protein 28childrenCOVID-19human endogenous retrovirusesinterferonSARS-CoV-2SETDB1TRIM28

Identifiers

PMID34299101
PMCPMC8303145
OpenAlexW3179794326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.